METROPOLIS

Metropolis Healthcare Share Price Metropolis Healthcare

₹1,739.65
-0.1 (-0.01%)
21 April, 2024 05:00 BSE: 542650 NSE: METROPOLISISIN: INE112L01020

Start SIP in Metropolis Healthcare

Start SIP

Metropolis Healthcare Performance

Day Range

  • Low 1,672
  • High 1,754
₹ 1,739

52 Week Range

  • Low 1,209
  • High 1,934
₹ 1,739
  • Open Price1,710
  • Previous Close1,740
  • Volume336772

Metropolis Healthcare Share Price

  • Over 1 Month +9.94%
  • Over 3 Month +8.49%
  • Over 6 Month +15.2%
  • Over 1 Year +36.65%

Metropolis Healthcare Key Statistics

P/E Ratio 71.4
PEG Ratio -4.3
Market Cap Cr 8,912
Price to Book Ratio 9
EPS 27.1
Dividend 0.2
Relative Strength Index 53.63
Money Flow Index 70.44
MACD Signal 26.69
Average True Range 67.9
Metropolis Healthcare Financials
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 269285256264
Operating Expenses Qtr Cr 211218198197
Operating Profit Qtr Cr 59675868
Depreciation Qtr Cr 24212022
Interest Qtr Cr 5666
Tax Qtr Cr 81198
Net Profit Qtr Cr 27312640
IndicatorMar 2023
Total Revenue Annual Cr 1,087
Operating Expenses Annual Cr 797
Operating Profit Annual in Cr 269
Depreciation Cr 85
Interest Annual Cr 27
Tax Annual Cr 40
Net Profit Annual Cr 139
IndicatorMar 2023
Cash from Operating Activity Annual Cr 238
Cash from Investing Activity Annual Cr 47
Cash from Financing Annual Activity Cr -288
Net Cash Flow Annual Cr -3
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 936
Fixed Assets Annual Cr 1,085
Total Non Current Assets Annual Cr 1,169
Total Current Assets Annual Cr 265
Total Assets Annual Cr 1,434
IndicatorMar 2023
Book Value Per Share Annual Rs 183
ROE Annual % 15
ROCE Annual % 17
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 27
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 291309277283
Operating Expenses Qtr Cr 226234214212
Operating Profit Qtr Cr 65756370
Depreciation Qtr Cr 25222123
Interest Qtr Cr 5666
Tax Qtr Cr 1012108
Net Profit Qtr Cr 27352933
IndicatorMar 2023
Total Revenue Annual Cr 1,163
Operating Expenses Annual Cr 860
Operating Profit Annual in Cr 288
Depreciation Cr 89
Interest Annual Cr 27
Tax Annual Cr 44
Net Profit Annual Cr 143
IndicatorMar 2023
Cash from Operating Activity Annual Cr 247
Cash from Investing Activity Annual Cr 47
Cash from Financing Annual Activity Cr -292
Net Cash Flow Annual Cr 2
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 988
Fixed Assets Annual Cr 685
Total Non Current Assets Annual Cr 1,199
Total Current Assets Annual Cr 303
Total Assets Annual Cr 1,502
IndicatorMar 2023
Book Value Per Share Annual Rs 193
ROE Annual % 14
ROCE Annual % 17
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 26

Metropolis Healthcare Technicals

EMA & SMA

Current Price
₹1,739.65
-0.1 (-0.01%)
pointer
  • Bullish Moving Average
  • ___
  • 11
  • Bearish Moving Average
  • ___
  • 5
  • 20 Day
  • ₹1,726.01
  • 50 Day
  • ₹1,690.64
  • 100 Day
  • ₹1,649.50
  • 200 Day
  • ₹1,589.20
  • 20 Day
  • ₹1,713.77
  • 50 Day
  • ₹1,692.89
  • 100 Day
  • ₹1,665.99
  • 200 Day
  • ₹1,556.40

Metropolis Healthcare Resistance and Support

PIVOT
₹1,721.75
Resistance
First Resistance 1,771.90
Second Resistance 1,804.15
Third Resistance 1,854.30
RSI 53.63
MFI 70.44
MACD Single Line 26.69
MACD 28.35
Support
First Resistance 1,689.50
Second Resistance 1,639.35
Third Resistance 1,607.10

Metropolis Healthcare Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 344,840 5,886,419 17.07
Week 449,182 7,204,883 16.04
1 Month 475,713 11,987,958 25.2
6 Month 413,887 14,850,273 35.88

Metropolis Healthcare Result Highlights

Metropolis Healthcare Synopsis

NSE-Medical-Services

Metropolis Healthcar is involved in the business activities of Activities of independent diagnostic/pathological laboratories. Company’s Total Operating Revenue is Rs. 1066.04 Cr. and Equity Capital is Rs. 10.24 Cr. for the Year ended 31/03/2023. Metropolis Healthcare Ltd. is a Public Limited Listed company incorporated on 01/03/2006 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L73100MH2000PLC192798 and registration number is 192798.
Market Cap 8,912
Sales 1,076
Shares in Float 2.56
No of funds
Yield 0.23
Book Value 9.52
U/D Vol ratio 1.6
LTDebt / Equity 3
Alpha
Beta 1.1

Metropolis Healthcare

Owner NameDec-23Sep-23Jun-23
Promoters 49.74%49.74%49.75%
Mutual Funds 16.01%14.02%13.34%
Insurance Companies 4.27%2.4%1.13%
Foreign Portfolio Investors 21.66%24.29%25.66%
Individual Investors 6.63%7.78%8.15%
Others 1.69%1.77%1.97%

Metropolis Healthcare Management

Name Designation
Dr. Sushil Kanubhai Shah Chairman & Executive Director
Mrs. Ameera Sushil Shah Managing Director
Mr. Hemant Sachdev Non Exe.Non Ind.Director
Mr. Vivek Gambhir Ind. Non-Executive Director
Mr. Sanjay Bhatnagar Ind. Non-Executive Director
Mr. Milind Shripad Sarwate Ind. Non-Executive Director
Ms. Anita Ramachandran Ind. Non-Executive Director

Metropolis Healthcare Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Metropolis Healthcare Corporate Action

Date Purpose Remarks
2024-02-02 Quarterly Results
2023-11-04 Quarterly Results & Interim Dividend
2023-08-02 Quarterly Results
2023-05-16 Audited Results
2023-02-10 Quarterly Results & Interim Dividend
Date Purpose Remarks
2023-11-17 INTERIM Rs.4.00 per share(200%)Interim Dividend
2023-02-23 INTERIM Rs.8.00 per share(400%)Interim Dividend (Revised)
2022-02-22 INTERIM Rs.8.00 per share(400%)Interim Dividend
2021-02-19 INTERIM Rs.8.00 per share(400%)Interim Dividend

Metropolis Healthcare FAQs

What is Share Price of Metropolis Healthcare ?

Metropolis Healthcare share price is ₹1,739 As on 21 April, 2024 | 04:46

What is the Market Cap of Metropolis Healthcare ?

The Market Cap of Metropolis Healthcare is ₹8912 Cr As on 21 April, 2024 | 04:46

What is the P/E ratio of Metropolis Healthcare ?

The P/E ratio of Metropolis Healthcare is 71.4 As on 21 April, 2024 | 04:46

What is the PB ratio of Metropolis Healthcare ?

The PB ratio of Metropolis Healthcare is 9 As on 21 April, 2024 | 04:46

Q2FY23